Meeting report: risk assessment of tamiflu use under pandemic conditions

Simple item page
dc.contributor.authorSinger, Andrew C.-
dc.contributor.authorHoward, Bruce M.-
dc.contributor.authorJohnson, Andrew C.-
dc.contributor.authorKnowles, Chris J.-
dc.contributor.authorJackman, Simon-
dc.contributor.authorAccinelli, Cesare-
dc.contributor.authorCaracciolo, Anna Barra-
dc.contributor.authorBernard, Ian-
dc.contributor.authorBird, Stephen-
dc.contributor.authorBoucard, Tatiana-
dc.contributor.authorBoxall, Alistair-
dc.contributor.authorBrian, Jayne V.-
dc.contributor.authorCartmell, Elise-
dc.contributor.authorChubb, Chris-
dc.contributor.authorChurchley, J.-
dc.contributor.authorCostigan, Sandra-
dc.contributor.authorCrane, Mark-
dc.contributor.authorDempsey, Michael J.-
dc.contributor.authorDorrington, Bob-
dc.contributor.authorEllor, Brian-
dc.contributor.authorFick, Jerker-
dc.contributor.authorHolmes, John-
dc.contributor.authorHutchinson, Tom-
dc.contributor.authorKarcher, Franz-
dc.contributor.authorKelleher, Samuel L.-
dc.contributor.authorMarsden, Peter-
dc.contributor.authorNoone, Gerald-
dc.contributor.authorNunn, Miles A.-
dc.contributor.authorOxford, John-
dc.contributor.authorRachwal, Tony-
dc.contributor.authorRoberts, Noel-
dc.contributor.authorRoberts, Mike-
dc.contributor.authorSacca, Maria Ludovica-
dc.contributor.authorSanders, Matthew-
dc.contributor.authorStraub, Jürg Oliver-
dc.contributor.authorTerry, Adrian-
dc.contributor.authorThomas, Dean-
dc.contributor.authorToovey, Stephen-
dc.contributor.authorTownsend, Rodney-
dc.contributor.authorVouivoulis, Nikolaos-
dc.contributor.authorWatts, Chris-
dc.date.accessioned2012-03-16T23:01:45Z
dc.date.available2012-03-16T23:01:45Z
dc.date.issued2008-11-30T00:00:00Z-
dc.description.abstractOn 3 October 2007, 40 participants with diverse expertise attended the workshop Tamiflu and the Environment: Implications of Use under Pandemic Conditions to assess the potential human health impact and environmental hazards associated with use of Tamiflu during an influenza pandemic. Based on the identification and risk-ranking of knowledge gaps, the consensus was that oseltamivir ethylester-phosphate (OE-P) and oseltamivir carboxylate (OC) were unlikely to pose an ecotoxicologic hazard to freshwater organisms. OC in river water might hasten the generation of OC-resistance in wildfowl, but this possibility seems less likely than the potential disruption that could be posed by OC and other pharmaceuticals to the operation of sewage treatment plants. The work-group members agreed on the following research priorities: a) available data on the ecotoxicology of OE-P and OC should be published; b) risk should be assessed for OC-contaminated river water generating OC-resistant viruses in wildfowl; c) sewage treatment plant functioning due to microbial inhibition by neuraminidase inhibitors and other antimicrobials used during a pandemic should be investigated: and e realistic worst-case exposure scenarios should be developed. Additional modeling would be useful to identify localized areas within river catchments that might be prone to high pharmaceutical concentrations in sewage treatment plant effluent. Ongoing seasonal use of Tamiflu in Japan offers opportunities for researchers to assess how much OC enters and persists in the aquatic environment.en_UK
dc.identifier.citationAndrew C. Singer, Bruce M. Howard, Andrew C. Johnson, et al. Meeting report: risk assessment of tamiflu use under pandemic conditions. Environmental Health Perspectives, Volume 116, number 11, November 2008, pp1563-1567
dc.identifier.issn0091-6765-
dc.identifier.urihttp://dx.doi.org/10.1289/ehp.11310-
dc.identifier.urihttp://dspace.lib.cranfield.ac.uk/handle/1826/7057
dc.language.isoen_UK-
dc.publisherNat Inst of Environ Health Sciences / The National Institute of Environmental Health Sciences (NIEHS)en_UK
dc.subjectantiviral drug ecotoxicology influenza pandemic pharmaceutical pollution sewage treatment plant Tamiflu neuraminidase inhibitors influenza-viruses oseltamivir treatment resistance susceptibilityen_UK
dc.titleMeeting report: risk assessment of tamiflu use under pandemic conditionsen_UK
dc.typeArticle-

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Meeting_report_risk_assessment_of_tamiflu-2008.pdf
Size:
125.15 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
18 B
Format:
Plain Text
Description:
Download

Collections

Staff publications (SAS)